Skip to main content
Company profile
Scynexis, Inc. logo

Scynexis, Inc.

Pipeline4 assets

  • SCY-770PXL-770 / AMP-activated protein kinase (AMPK) / Small Molecule / Rare Diseases / Nephrology
    Autosomal Dominant Polycystic Kidney Disease (ADPKD)Phase 2ActiveGlobal
  • SCY-247SCY-247 / 1,3-beta-glucan synthase / Small Molecule / Infectious Diseases
    Treatment and Prevention of Invasive Fungal InfectionsPhase 1ActiveUnited States
  • Fungerp analogs1,3-beta-glucan synthase / Small Molecule / Infectious Diseases
    Treatment of resistant fungiPreclinicalActiveGlobal
  • IbrexafungerpSCY-078 / BREXAFEMME / 1,3-beta-glucan synthase / Small Molecule / Infectious Diseases
    Vulvovaginal candidiasis (VVC) and Recurrent VVCApprovedActiveUnited StatesInvasive Candidiasis (IC)Phase 3ActiveGlobal

Latest news12 items

All news
Scynexis, Inc. • Endpoint Arena